Optimization of Zika Vaccine Production Using Small-Molecule Viral Sensitizers to Enhance Yields
Max Planck Institute’s latest publication combines Design of Experiments (DoE), synergy calculations, generative‑AI‑designed scale‑down reactors, and cost modelling to show how Virica’s GMP‑ready, small molecule Viral Sensitizers (VSE™) serve as a simple media additive that significantly boosts Zika‑vaccine production. A single additive step can translate into multi-fold productivity gains and double-digit cost savings, an attractive route to faster, more economical, pandemic-ready vaccine manufacturing.
Key takeaways:
- Titer increases up to 7X across all three cell lines after a single VSE addition
- Further synergistic titer increases after multi-dose VSE evaluation using DoE
- Titer increases up to 8X in 3D-printed scale-down mimics of 200L or 2000L Xcellerex bioreactors
- Up to 61% reduction in cost per dose for a 3X yield increase at 2000L